Literature DB >> 4039651

[Polyneuropathy after cisplatin treatment].

C Meier, A Goldhirsch, C Hess, J Bazarian, R Greiner, M Beer.   

Abstract

Polyneuropathy developed in 7 of 87 women who had been treated with cis-platinum for ovarian carcinoma. Distal disturbances of sensitivity were clinically prominent, the emphasis being on disturbed vibratory perception and acrognosis. No relevant signs of motor dysfunction were noticed, neither clinically nor neurophysiologically. Sural biopsies taken from two women revealed a primary axonal degeneration, mostly affecting the myelinic fibres of large diameter. In 3 cases mild reversion was seen, and in 4 cases no definite reversion, of the disturbed functions - uncertain gait and clumsiness of the hands - during the follow-up period of 6 to 30 months.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039651     DOI: 10.1055/s-2008-1068894

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies.

Authors:  Frederic Jungbauer; Lena Huber; Sonja Ludwig; Nicole Rotter; Beatrice Walter; Lena Zaubitzer; Anne Lammert
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.